DK1682111T3 - Enos-transkriptionsenhancere til anvendelse inden for celleterapien af iskæmiske hjertesygdomme - Google Patents

Enos-transkriptionsenhancere til anvendelse inden for celleterapien af iskæmiske hjertesygdomme

Info

Publication number
DK1682111T3
DK1682111T3 DK04818113.5T DK04818113T DK1682111T3 DK 1682111 T3 DK1682111 T3 DK 1682111T3 DK 04818113 T DK04818113 T DK 04818113T DK 1682111 T3 DK1682111 T3 DK 1682111T3
Authority
DK
Denmark
Prior art keywords
heart disease
cell therapy
ischemic heart
transcription enhancers
enos transcription
Prior art date
Application number
DK04818113.5T
Other languages
English (en)
Inventor
Andreas Zeiher
Stefanie Dimmeler
Christopher Heeschen
Hartmut Ruetten
Original Assignee
Sanofi Aventis Deutschland
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis Deutschland filed Critical Sanofi Aventis Deutschland
Application granted granted Critical
Publication of DK1682111T3 publication Critical patent/DK1682111T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Epidemiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK04818113.5T 2003-11-06 2004-10-22 Enos-transkriptionsenhancere til anvendelse inden for celleterapien af iskæmiske hjertesygdomme DK1682111T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP03025512A EP1529525A1 (en) 2003-11-06 2003-11-06 ENOS transcription enhancers for use in the cell therapy of ischemic heart diseases
PCT/EP2004/011944 WO2005044249A1 (en) 2003-11-06 2004-10-22 Enos transcription enhancers for use in the cell therapy of ischemic heart diseases

Publications (1)

Publication Number Publication Date
DK1682111T3 true DK1682111T3 (da) 2010-04-26

Family

ID=34429288

Family Applications (1)

Application Number Title Priority Date Filing Date
DK04818113.5T DK1682111T3 (da) 2003-11-06 2004-10-22 Enos-transkriptionsenhancere til anvendelse inden for celleterapien af iskæmiske hjertesygdomme

Country Status (21)

Country Link
EP (3) EP1529525A1 (da)
JP (1) JP4705581B2 (da)
KR (1) KR101133943B1 (da)
CN (1) CN100563643C (da)
AR (1) AR046572A1 (da)
AT (1) ATE454143T1 (da)
AU (1) AU2004286776B2 (da)
BR (1) BRPI0416313A (da)
CA (1) CA2544632C (da)
CY (1) CY1112015T1 (da)
DE (1) DE602004025024D1 (da)
DK (1) DK1682111T3 (da)
ES (1) ES2339252T3 (da)
IL (1) IL174807A (da)
PE (1) PE20050486A1 (da)
PL (1) PL1682111T3 (da)
PT (1) PT1682111E (da)
SI (1) SI1682111T1 (da)
TW (1) TW200528119A (da)
UY (1) UY28605A1 (da)
WO (1) WO2005044249A1 (da)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1529525A1 (en) 2003-11-06 2005-05-11 Aventis Pharma Deutschland GmbH ENOS transcription enhancers for use in the cell therapy of ischemic heart diseases
JP4487051B2 (ja) 2005-08-29 2010-06-23 独立行政法人科学技術振興機構 ダチョウを用いた抗体、及びその作製方法
WO2014042292A1 (ko) * 2012-09-12 2014-03-20 연세대학교 산학협력단 단백질 인산화효소 c 활성화제를 포함하는 줄기세포 부착 촉진용 조성물 및 줄기세포의 부착 촉진 방법
GB201601301D0 (en) * 2016-01-25 2016-03-09 Takeda Pharmaceutical Novel compounds

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2368677C (en) * 1999-03-30 2012-07-10 Ran Kornowski Intramyocardial injection of autologous bone marrow
TWI243164B (en) * 2001-02-13 2005-11-11 Aventis Pharma Gmbh Acylated indanyl amines and their use as pharmaceuticals
AR035431A1 (es) * 2001-02-13 2004-05-26 Aventis Pharma Gmbh 6,7,8,9-tetrahidro-5h-benzocicloheptenil aminas aciladas, un metodo para su sintesis, composiciones farmaceuticas y el uso de dichos compuestos para la fabricacion de medicamentos
TWI241190B (en) * 2001-02-13 2005-10-11 Aventis Pharma Gmbh 4-Fluoro-N-indan-2-yl benzamide and its use as pharmaceutical
PE20020856A1 (es) * 2001-02-13 2002-11-11 Aventis Pharma Gmbh 1,2,3,4-tetrahidronaftil aminas aciladas
EP1529525A1 (en) 2003-11-06 2005-05-11 Aventis Pharma Deutschland GmbH ENOS transcription enhancers for use in the cell therapy of ischemic heart diseases

Also Published As

Publication number Publication date
EP1529525A1 (en) 2005-05-11
TW200528119A (en) 2005-09-01
EP2198861B1 (en) 2014-06-25
CA2544632C (en) 2012-09-04
KR20060108658A (ko) 2006-10-18
CA2544632A1 (en) 2005-05-19
ATE454143T1 (de) 2010-01-15
CY1112015T1 (el) 2015-11-04
CN100563643C (zh) 2009-12-02
ES2339252T3 (es) 2010-05-18
PE20050486A1 (es) 2005-10-06
AR046572A1 (es) 2005-12-14
PL1682111T3 (pl) 2010-06-30
BRPI0416313A (pt) 2006-12-26
WO2005044249A1 (en) 2005-05-19
SI1682111T1 (sl) 2010-04-30
CN1878544A (zh) 2006-12-13
JP2007509873A (ja) 2007-04-19
IL174807A0 (en) 2008-04-13
IL174807A (en) 2011-05-31
PT1682111E (pt) 2010-02-10
EP1682111A1 (en) 2006-07-26
KR101133943B1 (ko) 2012-04-13
EP2198861A3 (en) 2010-12-15
AU2004286776A1 (en) 2005-05-19
UY28605A1 (es) 2005-05-31
AU2004286776B2 (en) 2010-05-27
JP4705581B2 (ja) 2011-06-22
HK1095527A1 (zh) 2007-05-11
EP2198861A2 (en) 2010-06-23
DE602004025024D1 (de) 2010-02-25
EP1682111B1 (en) 2010-01-06

Similar Documents

Publication Publication Date Title
DE502005007353D1 (de) Zervikale zwischenwirbelprothese
EP1597276A4 (en) Therapeutic molecules
DE60315135D1 (de) Therapiesonde
DE602005001560D1 (de) Zugangskanüle
DK1919450T3 (da) Antihistamin- og corticosteroidholdig liposomsammensætning og dens anvendelse til fremstilling af et lægemiddel til behandling af rhinitis og beslægtede lidelser
DK2573166T3 (da) Fremgangsmåder til fremstilling af T-celler til celleterapi
DK1575951T3 (da) Heterocykliske forbindelser, fremgangsmåder til fremstilling deraf og deres anvendelse i terapi
EP1629557A4 (en) Polyimide MATRIX ELEKTROLYT
DK1487828T3 (da) Morpholinyl-urea-derivater til anvendelse til behandling af inflammatoriske sygdomme
DK1708994T3 (da) Aryloxyalkylcarbamatderivater, fremstilling og anvendelse herfra inden for terapi
DK1597171T3 (da) Terapeutisk mikroskum
IS2736B (is) Makrólíðsamrunaefnasambönd@með@bólgueyðandi@virkni
DE602004025444D1 (de) Transdermales therapeutisches System von Gestoden
DK1594859T3 (da) Indazolamider med analgetisk aktivitet
DK1545710T3 (da) Anvendelse af N-(3-methoxy-5-methylpyrazin-2-yl)-2-(4-[1,3,4-oxadiazol-2-yl]-phenyl)-pyridin-3-sulfonamid til behandling af cancer
DK1682111T3 (da) Enos-transkriptionsenhancere til anvendelse inden for celleterapien af iskæmiske hjertesygdomme
DK1687297T3 (da) Triazindimerer til behandling af autoimmunsygdomme
DK1771415T3 (da) 2-(1H-indolylsulfanyl)-arylaminderivater til anvendelse i behandlingen af affektive sygdomme, smerte, ADHD og stressinkontinens
DK1496918T3 (da) Anvendelse af natriummetaarsenit til behandling af tumorer
FR2872694B1 (fr) Instrument medical
DK1598350T3 (da) Pyrrolidin- og thiazolidinforbindelser, fremgangsmåde til fremstilling heraf og deres anvendelse til behandling af hypoglykæmi og diabetes II
DK1622892T3 (da) Indazoler med analgetisk aktivitet
DE602005010492D1 (de) EKG-Referenzwertberechnung
DK1680405T3 (da) Bengamidderivater og deres anvendelse til behandling af kræftsygdomme
DK2301576T3 (da) Terapeutisk anvendelse af anti-CS1-antistoffer